Company intelligence / Profile preview

BioPro Stem Technology

Ownership
Private
Development stage
Commercial
01

Overview

Biopro Stem Technology has demonstrated safety and efficacy of its autologous stem cell therapies in Ukrainian clinical settings, particularly for vascular disease, diabetes complications, liver cirrhosis, and autoimmune disorders. The company collaborates closely with national medical institutions to advance regenerative medicine using its proprietary ShorDiCell® platform.

Patient outcomes include improved tissue regeneration markers in preclinical studies and positive real-world results reported by patients across several serious chronic conditions.

Awarded the International Star for Quality Gold Category in 2015 for innovation/service quality.

Pipeline breadth: Estimated at least several programs based on multiple indications treated.

Therapeutic areas
EndocrinologyImmunologyGastroenterologyCardiovascularInfectious Diseases
Modalities
Cell therapyAutologous human stem cellsAdipose-derived mesenchymal stem cells
Industry
Biotech
02

Partnerships

National Academy of Medical Sciences of UkraineState Institute of Genetic and Regenerative Medicine NAMS UkraineMinistry of Defence Ukraine/National Military Medical Clinical Center “Main Military Clinical Hospital”

Beyond the preview

Go deeper on BioPro Stem Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPro Stem Technology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call